TAM
CTOR

Terrapin Asset Management’s Citius Oncology CTOR Stock Holding History

Terrapin Asset Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$808K Hold
75,000
– – 0.92% 26
2023
Q2 		$790K Hold
75,000
– – 1.02% 26
2023
Q1 		$777K Hold
75,000
– – 1.01% 25
2022
Q4 		$762K Buy
+75,000
New +$760K 0.78% 27

Other funds holding CTOR

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Terrapin Asset Management's CTOR Position: Q3 2023 in Review

Terrapin Asset Management held its Citius Oncology (CTOR) position steady in Q3 2023 at 75,000 shares worth $808K. The position accounts for 0.92% of the portfolio, ranked #26.

Terrapin Asset Management first reported a position in CTOR in Q4 2022 and has held it in 4 quarters since. 23 funds tracked by Wall St. Rank hold CTOR as of Q3 2023.

  • Terrapin Asset Management held 75,000 shares of Citius Oncology worth $808K as of Q3 2023.
  • Terrapin Asset Management left its Citius Oncology share count unchanged in Q3 2023.
  • Citius Oncology made up 0.92% of Terrapin Asset Management's portfolio in Q3 2023, its #26 holding.
  • Terrapin Asset Management first reported a position in Citius Oncology in Q4 2022 and has held it in 4 quarters since.
  • 23 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2023.

Based on Terrapin Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.